148 related articles for article (PubMed ID: 1431903)
1. Extracellular striatal concentrations of endogenous 3,4-dihydroxyphenylalanine in the absence of a decarboxylase inhibitor: a dynamic index of dopamine synthesis in vivo.
Carboni E; Tanda G; Di Chiara G
J Neurochem; 1992 Dec; 59(6):2230-6. PubMed ID: 1431903
[TBL] [Abstract][Full Text] [Related]
2. Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats.
Westerink BH; De Vries JB; Duran R
J Neurochem; 1990 Feb; 54(2):381-7. PubMed ID: 1967629
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
[TBL] [Abstract][Full Text] [Related]
4. Transmitter-like basal and K(+)-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis.
Nakamura S; Goshima Y; Yue JL; Misu Y
J Neurochem; 1992 Jan; 58(1):270-5. PubMed ID: 1345766
[TBL] [Abstract][Full Text] [Related]
5. Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices.
Goshima Y; Kubo T; Misu Y
J Neurochem; 1988 Jun; 50(6):1725-30. PubMed ID: 2897424
[TBL] [Abstract][Full Text] [Related]
6. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
7. Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115).
Bräutigam M; Laschinski G; Kittner B; Herken H
Biochem Pharmacol; 1985 Apr; 34(7):941-7. PubMed ID: 3921032
[TBL] [Abstract][Full Text] [Related]
8. Transmitter-like 3,4-dihydroxyphenylalanine is tonically released by nicotine in striata of conscious rats.
Nakamura S; Goshima Y; Yue JL; Miyamae T; Misu Y
Eur J Pharmacol; 1992 Nov; 222(1):75-80. PubMed ID: 1361443
[TBL] [Abstract][Full Text] [Related]
9. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.
Acquas E; Carboni E; de Ree RH; Da Prada M; Di Chiara G
J Neurochem; 1992 Jul; 59(1):326-30. PubMed ID: 1613509
[TBL] [Abstract][Full Text] [Related]
10. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B
J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483
[TBL] [Abstract][Full Text] [Related]
11. [The measurement of tyrosine hydroxylase activity in the brain of conscious rats].
Wang W; Zhao DZ; Wang WX; Sun BH
Zhongguo Zhong Yao Za Zhi; 2002 Feb; 27(2):132-5. PubMed ID: 12774389
[TBL] [Abstract][Full Text] [Related]
12. Long-term depression in striatal dopamine release monitored by in vivo voltammetry in free moving rats.
Abraini JH; Raharison L; Rostain JC
Brain Res; 1991 May; 548(1-2):256-9. PubMed ID: 1678298
[TBL] [Abstract][Full Text] [Related]
13. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
Persson SA
Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
[TBL] [Abstract][Full Text] [Related]
14. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
[TBL] [Abstract][Full Text] [Related]
15. Effects of l-stepholidine on tyrosine hydroxylase activity in rat corpus striatum.
Guo X; Chen LJ; Buda M; Jin GZ
Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):289-92. PubMed ID: 1360740
[TBL] [Abstract][Full Text] [Related]
16. Effects of drugs interfering with dopamine and noradrenaline biosynthesis on the endogenous 3,4-dihydroxyphenylalanine levels in rat brain.
Westerink BH; van Es TP; Spaan SJ
J Neurochem; 1982 Jul; 39(1):44-51. PubMed ID: 6123552
[TBL] [Abstract][Full Text] [Related]
17. Dopamine-releasing action of 6R-L-erythro-tetrahydrobiopterin: analysis of its action site using sepiapterin.
Koshimura K; Miwa S; Watanabe Y
J Neurochem; 1994 Aug; 63(2):649-54. PubMed ID: 7518501
[TBL] [Abstract][Full Text] [Related]
18. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
Wachtel SR; Abercrombie ED
J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
[TBL] [Abstract][Full Text] [Related]
19. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
Gołembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
